From a molecular laboratory viewpoint, Relafen 750 ( its salt form) presents a unique case. Its mechanism of action primarily involves inhibiting cyclooxygenase catalysts , specifically COX-1 and COX-2, thereby reducing prostaglandin production . This leads to decreased pain and temperature . The medication's relatively long persistence and specifi